Yoshihiro Inamoto

34PUBLICATIONS
136CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisImmunogenetics (incl. genetic immunology)Gastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 24, 2026
Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

|Mar 17, 2026
Valemetostat Therapy for Relapsed Adult T-Cell Leukemia/Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation.

Shota Furukawa, Ayumu Ito, Mamoru Nagata

|Nov 26, 2025
Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study.

Koji Kato, Yoshihiro Inamoto, Toshiro Kawakita

|Nov 17, 2025
Advances in treatment of chronic graft-versus-host disease.

Takanobu Morishita, Yoshihiro Inamoto

|Jul 01, 2025
Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC.

Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou

|May 20, 2025
Prognostic impact of histopathologic features including histological grading and immunohistochemistry-positive cell counts in cytomegalovirus-gastrointestinal disease after allogeneic hematopoietic cell transplantation.

Masatomo Kuno, Takashi Tanaka, Akiko Miyagi Maeshima

Pageof 6

Frequent Collaborators

7 joint publications

Junya Kanda

6 joint publications

Yoshiko Atsuta

6 joint publications

Naoyuki Uchida

4 joint publications

Yuta Katayama